Etiopathogenesis of Mucocutaneous Lesions in Behçet’s Disease

Conference paper
Part of the Verhandlungen der Deutschen Dermatologischen Gesellschaft book series (VDGDERMATOLOGIE, volume 32)


Although more than 4 decades have passed since Behçet defined his triple symptom complex, the exact aetiology and pathogenesis of this process are still undecided. The oral, genital and ocular manifestations initially described have since been extended to include skin, joints, brain, blood vessels, intestine, heart, lungs and kidneys as well [4, 11].


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alm L, Oberg L (1945) Djugorsok Vid SR Behçet’s syndrome. Nord Med 25: 603–604Google Scholar
  2. 2.
    Askenase PW (1977) Role of basophils, mast cells, and vasoamines in hypersensitivity reactions with a delayed time course. Prog Allergy 23: 199–320PubMedGoogle Scholar
  3. 3.
    Behçet H (1937) Über rezidivierende, aphthöse, durch einen Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105: 1152–1157Google Scholar
  4. 4.
    Berlin C (1960) Behçet’s disease as a multiple symptom complex: report of ten cases. Arch Dermatol 82: 73–79CrossRefGoogle Scholar
  5. 5.
    Chajek T, Fainaru M (1973) Behçet’s disease with decreased fibrinolysis and superior vena caval occlusion. Br Med J 1: 782–783PubMedCrossRefGoogle Scholar
  6. 6.
    Cunliffe WJ (1969) An association between cutaneous vasculitis and decreased blood fibrinolytic activity. Lancet 1: 1239–1240PubMedCrossRefGoogle Scholar
  7. 7.
    Denman AM, Pinder M (1974) Measurement of immunological function in man: Interaction between virus and human leukocytes. Proc Roy Soc Med 67: 1219–1221PubMedGoogle Scholar
  8. 8.
    Dvorak HF (1976) Cutaneous basophil hypersensitivity. J Allerg Clin Immunol 58: 229–240CrossRefGoogle Scholar
  9. 9.
    Dvorak HF, Dvorak AM (1972) Basophils mast cells and cellular immunity in animals and man. Human Pathol 3: 454–456CrossRefGoogle Scholar
  10. 10.
    Evans HD, Pallis GA, Spillane JD (1959) Involvement of nervous system in Behçet’s syndrome. Report of three cases and isolation of virus. Lancet II: 349–353Google Scholar
  11. 11.
    Haim S (1970) Behçet’s syndrome as a generalized systemic disease. Harefuah 78: 63–65PubMedGoogle Scholar
  12. 12.
    Haim S, Gideoni O, Barzilai A (1977) The histocompatibility antigens in patients with Behçet’s disease. Acta Derm Venereol (Stockh) 57: 243–245Google Scholar
  13. 13.
    Haim S, Gilhar A, Mekori T, Segal R (1979) Leucocyte migration inhibition in Behçet’s disease. Dermatologica 159: 302–306PubMedCrossRefGoogle Scholar
  14. 14.
    Haim S, Mekori T, Sobel JD, Robinson E (1976) Aspects of lymphocyte function in Behçet’s disease. Dermatologica 153: 34–37PubMedCrossRefGoogle Scholar
  15. 15.
    Haim S, Sobel JD, Friedman-Birnbaum R (1974) Thrombophlebitis. A cardinal symptom of Behçet’s disease. Acta Derm Venereol (Stockh) 54: 299–301Google Scholar
  16. 16.
    Haim S, Sobel JD, Friedman-Birnbaum R, Lichtig C (1976) Histological and direct immunofluorescence study of cutaneous hyperreactivity in Behçet’s disease. Br J Dermatol 95: 631–636PubMedCrossRefGoogle Scholar
  17. 17.
    Kawachi-Takahashi S, Takahashi M, Kogura M, Kawashima T (1974) Elevation of serum C9 level associated with Behçet’s disease. Jap J Exp Med 44: 485–487Google Scholar
  18. 18.
    Kogure M, Shimada K, Hara HG (1971) Complement titer in patients with Behçet’s disease. Acta Soc Ophthal Jap 75: 1260–1268PubMedGoogle Scholar
  19. 19.
    Lehner T (1967) Stimulation of lymphocyte transformation by tissue homogenates in recurrent oral ulcerations Immunology 13: 159–166PubMedGoogle Scholar
  20. 20.
    Lehner T (1969) Characterization of mucosal antibodies in recurrent aphthous ulceration and Behçet’s syndrome. Arch Oral Biol 14: 843–853PubMedCrossRefGoogle Scholar
  21. 21.
    Lehner T (1972) Immunological aspects of recurrent oral ulcers. Oral Surg 23: 80–85CrossRefGoogle Scholar
  22. 22.
    Lehner T (Ref. 10) Immunological aspects of Behçet’s syndrome, pp 203–211Google Scholar
  23. 23.
    Levinsky RJ, Lehner T (1978) Circulating soluble immune complexes in recurrent oral ulceration and Behçet’s syndrome. Clin Exp Immunol 32: 193–198PubMedGoogle Scholar
  24. 24.
    Lichtig C, Haim S, Gilhar A, Hammel I, Ludatscher R (in press) Mast cells in Behçet’s disease: Ultrastructural and histamine content studies. DermatologicaGoogle Scholar
  25. 25.
    Lichtig C, Haim S, Hammel I, Friedman-Birnbaum R (1980) The quantification and significance of mast cells in Behçet’s disease. Br J Dermatol 102: 255–259PubMedCrossRefGoogle Scholar
  26. 26.
    Matsumura N, Mizushima Y (1975) Leucocyte movement and colchicine treatment in Behçet’s disease (letter). Lancet 11: 813CrossRefGoogle Scholar
  27. 27.
    Nishiyama S, Murakami M, Hori Y (Ref. 10) The etiological role of organic chloride in Behçet’s disease, p 60Google Scholar
  28. 28.
    O’Duffy JD, Corney JA, Deodhar S (1971) Behçet’s disease: report of 10 cases, 3 with new manifestations. Ann Intern Med 75: 561–570PubMedGoogle Scholar
  29. 29.
    Ohno S, Nakayama E, Sugiura S, Itakura K, Aoki K, Aizawa M (1975) Specific histocompatibility antigens associated with Behçet’s disease. Am J Ophthal 80: 636–640Google Scholar
  30. 30.
    Ohno S, Aoki K, Sugiora S, Nakayama E, Itakura K, Aizawa M (1973) HL-A5 and Behçet’s disease (letter). Lancet 11: 1383CrossRefGoogle Scholar
  31. 31.
    Oshima Y, Shimzu T, Yokohari R, Matsumato T, Kano K, Kugami T, Nagaya H, Marugama R (1963) Clinical study on Behçet’s syndrome. Ann Rheum Dis 22: 36–45PubMedCrossRefGoogle Scholar
  32. 32.
    Rogers RS, Sams WM, Shorter RG (1974) Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Behçet’s disease. Arch Dermatol 109: 361–363PubMedCrossRefGoogle Scholar
  33. 33.
    Rubenstein LJ, Urich H (1963) Meningoencephalitis of Behçet’s disease. Case report with pathological findings. Brain 86: 151–160CrossRefGoogle Scholar
  34. 34.
    Sezar N (1953) Isolation of virus as a cause of Behçet’s disease. Am J Ophthal 36: 301–315Google Scholar
  35. 35.
    Shimizu K, Ishikawa S, Miyata M, Yoshida H, Kubo H (Ref. 10) Relationships between the changes of serum copper levels and ocular attacks in Behçet’s disease (an etiological consideration), pp 61–72Google Scholar
  36. 36.
    Shishido A (1976) Nucleocapsid like structures in the tissues of Behçet’s disease patients. Jap J Med Sci Biol 29: 99–104PubMedGoogle Scholar
  37. 37.
    Shishido A, Yamanouchi K (1979) Viriological studies on etiology of Behçet’s disease in Japan. In: Dillen N, Koniç M, Ovül C (eds) Behçet’s disease. International Congress Series 467, Excerpta Medica, Amsterdam Oxford, pp 73–76Google Scholar
  38. 38.
    Sobel JD, Haim S, Obedeanu N, Meshulam T, Merzbach D (1977) Polymorphonuclear leucocyte function in Behçet’s disease. Clin Pathol 30: 250–253CrossRefGoogle Scholar
  39. 39.
    Sugiura S, Aoki K, Fujika K, Kono M (1972) Serum antibodies to various pathogenic agents and lymphocytic transformation in Behçet’s disease. Acta Soc Ophthal Jap 76: 635–641PubMedGoogle Scholar
  40. 40.
    Williams BD, Lehner T (1977) Immune complexes in recurrent oral ulceration and Behçet’s syndrome. Br Med J 1: 1387–1390PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • S. Haim
    • 1
  1. 1.Dept. of DermatologyRambam Medical Center and Technicon Faculty of MedicineHaifaIsrael

Personalised recommendations